Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2017 1
2019 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 5 Pulmonary Fibrosis, CTCAE"
Page 1
Weight loss in nintedanib-treated patients with idiopathic pulmonary fibrosis.
Tomioka H, Iwabayashi M, Yokota M, Hashimoto R, Amimoto H. Tomioka H, et al. Pulm Pharmacol Ther. 2023 Jun;80:102213. doi: 10.1016/j.pupt.2023.102213. Epub 2023 Mar 29. Pulm Pharmacol Ther. 2023. PMID: 37001796
There was a significant difference in overall survival between patients with CTCAE grade 2-vs-grade<2 (median survival of 25.5 months and 55.2 months, p = 0.014). In the model adjusting for age, sex and lung function, weight loss CTCAE gra …
There was a significant difference in overall survival between patients with CTCAE grade 2-vs-grade<2 (median surviv …
Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Hozumi H, Hasegawa H, Miyashita K, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Hashimoto D, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T. Hozumi H, et al. Respirology. 2019 Aug;24(8):792-798. doi: 10.1111/resp.13506. Epub 2019 Feb 25. Respirology. 2019. PMID: 30803100 Free article.
BACKGROUND AND OBJECTIVE: Acute exacerbation (AE) is a leading cause of death in patients with idiopathic pulmonary fibrosis (IPF). Although optimal treatment for AE-IPF remains unclear, high-dose corticosteroids (CS) with/without immunosuppressants, including intra …
BACKGROUND AND OBJECTIVE: Acute exacerbation (AE) is a leading cause of death in patients with idiopathic pulmonary fibrosis ( …
Early CT findings of tomotherapy-induced radiation pneumonitis after treatment of lung malignancy.
Park HJ, Kim KJ, Park SH, Kay CS, Oh JS. Park HJ, et al. AJR Am J Roentgenol. 2009 Sep;193(3):W209-13. doi: 10.2214/AJR.08.2298. AJR Am J Roentgenol. 2009. PMID: 19696261
These 25 patients, with a total of 77 target lesions, were enrolled for the analysis. We evaluated pulmonary toxicity by the Common Toxicity Criteria for Adverse Events (CTCAE) method and retrospectively analyzed the CT findings of radiation pneumonitis, focusing on …
These 25 patients, with a total of 77 target lesions, were enrolled for the analysis. We evaluated pulmonary toxicity by the Common T …
Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis.
Ikeda S, Sekine A, Baba T, Yamanaka Y, Sadoyama S, Yamakawa H, Oda T, Okuda R, Kitamura H, Okudela K, Iwasawa T, Ohashi K, Takemura T, Ogura T. Ikeda S, et al. Sci Rep. 2017 Sep 7;7(1):10811. doi: 10.1038/s41598-017-11321-x. Sci Rep. 2017. PMID: 28883482 Free PMC article.
After the commercialization of nintedanib in Japan, a high incidence of hepatotoxicity resulting in treatment interruption was noted in idiopathic pulmonary fibrosis (IPF) patients treated with nintedanib in our hospital. ...Body surface area (BSA) was significantly …
After the commercialization of nintedanib in Japan, a high incidence of hepatotoxicity resulting in treatment interruption was noted in idio …